Humacyte Inc. (NASDAQ: HUMA)
$8.08
-0.7100 ( -8.08% ) 2.5M
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
Market Data
Open
$8.08
Previous close
$8.79
Volume
2.5M
Market cap
$962.20M
Day range
$8.04 - $8.86
52 week range
$1.96 - $9.97
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 12, 2023 |
4 | Insider transactions | 1 | Dec 12, 2023 |
4 | Insider transactions | 1 | Dec 12, 2023 |
4 | Insider transactions | 1 | Dec 12, 2023 |
4 | Insider transactions | 1 | Nov 21, 2023 |
8-k | 8K-related | 15 | Nov 09, 2023 |
10-q | Quarterly Reports | 77 | Nov 09, 2023 |
4 | Insider transactions | 1 | Oct 10, 2023 |
4 | Insider transactions | 1 | Oct 10, 2023 |
4 | Insider transactions | 1 | Sep 15, 2023 |